Benchmark Financial Wealth Advisors, LLC Amgen Inc Transaction History
Benchmark Financial Wealth Advisors, LLC
- $340 Million
- Q4 2025
A detailed history of Benchmark Financial Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Benchmark Financial Wealth Advisors, LLC holds 1,331 shares of AMGN stock, worth $454,816. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,331
Previous 855
55.67%
Holding current value
$454,816
Previous $241,000
88.38%
% of portfolio
0.13%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding AMGN
# of Institutions
3,348Shares Held
429MCall Options Held
6.11MPut Options Held
5.83M-
Vanguard Group Inc Valley Forge, PA54.8MShares$18.7 Billion0.29% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$10 Billion0.3% of portfolio
-
Capital International Investors Los Angeles, CA19.2MShares$6.56 Billion0.92% of portfolio
-
Capital World Investors Los Angeles, CA18.8MShares$6.42 Billion0.76% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $183B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...